Decipher Labs Limited share price
BSE: DECIPHER
Key numbers
- Market cap
- ₹ 6.1 Cr
- Current price
- ₹ 6.00
- 52-week high / low
- ₹ 11 / 5
- Stock P/E
- -
- Book value
- ₹ 20.2
- Dividend yield
- 0.00%
- ROCE
- -16.6%
- ROE
- -14.2%
- Debt to equity
- 0.02
- Sales growth (3 yrs)
- -32.4%
- Profit growth (3 yrs)
- -
- 1-year return
- -42.6%
About Decipher Labs Limited
Decipher Labs Limited, together with its subsidiaries, manufactures, markets, sells, and trades in pharmaceutical drugs in India and internationally. It operates through two segments, Manufacturing and Trading of Pharmaceutical Drugs and Consultancy. The company offers branded and finished formulations, bulk drugs, and chemicals. It also provides information technology (IT) consultancy services comprising technology integration and systems consulting, software development consulting, and management of IT projects. In addition, the company offers ERP implementation, mobile and cloud solutions, product development, and offshore services. It serves formulators, manufacturers, and research and development agencies. The company was formerly known as Combat Drugs Limited and changed its name to Decipher Labs Limited in January 2020. Decipher Labs Limited was incorporated in 1986 and is based in Hyderabad, India.
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 3 | 4 | 3 | 4 | 2 |
| Operating profit | -3 | 0 | -0 | 0 | -2 |
| Net profit | -3 | 0 | -1 | 1 | -2 |
| EPS (₹) | -3.39 | 0.02 | -0.53 | -0.35 | -2.16 |
Peers in Drug Manufacturers - Specialty & Generic
Data for information only, not investment advice. Prices end of day.